Among the most-read coverage for the annual meeting were presentations on the potential and costs of cell and gene therapies, ...

I was diagnosed with general anxiety disorder when I was very young—I think I may have been in elementary school. Those early ...

Consistent data from high-quality clinical studies will better inform clinical practices, guidelines and policy decisions, ...

In addition, they emphasized that the CPIC (Clinical Pharmacogenetics Implementation Consortium) and FDA (Food and Drug Administration) advocate for the use of PGx testing, specifically testing CYP2D6 ...

The genetic testing services market is poised for robust growth, with substantial advancements in genetic technologies and ...

The test does not predict which antidepressant will work best, but is being used to help suggest which ones may not work and which ones may have the greatest side effects. Pharmacogenomic testing ...

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today provided an update on its engagement with UnitedHealthcare (UNH) following the Nov 1, 2024 publication ...

Mayo Clinic researchers found that a gene variant, the TPMT∗8 allele, is associated with reduced metabolism of the thiopurine ...

Mayo Clinic researchers found that a gene variant, the TPMT∗8 allele, is associated with reduced metabolism of the thiopurine class of drugs. TPMT∗8 is relatively common in individuals of African or ...

The GeneSight Psychotropic test from Myriad Genetics is the category-leading pharmacogenomic test for more than 60 medications commonly prescribed for depression, anxiety, ADHD, and other ...